A Multicenter Phase Ii Trial of Nab-Paclitaxel in Combination with Capecitabine in Patients (Pts) with Her-2 Negative and Triple Negative Advanced Breast Cancer (Abc): an Interim AnalysisMariangela Ciccarese, Saverio Cinieri, Laura Orlando et al.|Annals of Oncology|2014Cited by 0
A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?Mariangela Ciccarese, Paola Schiavone, Evaristo Maiello et al.|The Breast Journal|2020Cited by 0